Abstract:Hydroxychloroquine enantiomers was selectivity separated by di‐p‐anisoyl‐L‐tartaric acid through forming diastereomeric salt. Using carboxymethyl‐β‐cyclodextrin as the chiral mobile phase agent, the optical purity of hydroxychloroquine enantiomers in the less salt of S‐Hydroxychloroquine·2di‐p‐anisoyl‐L‐tartaric acid was determined conveniently and successfully on the RP‐HPLC of OSD‐C18 column. Hydroxychloroquine (HCQ), 2‐([4‐([7‐Chloro‐4‐quinolyl]amino)pentyl]ethylamino)ethanol, exhibited significant biological activity, while its side effects cannot be overlooked. The RP‐HPLC enantio‐separation was investigated for cost‐effective and convenient optical purity analysis of HCQ. The thermodynamic resolution of Rac‐HCQ, driven by enthalpy and entropy, was achieved on the C18 column using Carboxymethyl‐β‐cyclodextrin (CM‐β‐CD) as the chiral mobile phase agent (CMPA). The effects of CCM‐β‐CD, pH, and triethylamine (TEA) V% on the enantio‐separation process were explored. Under the optimum conditions at 24°C, the retention times for the two enantiomers were tR1=29.39min and tR2=32.42min , resulting in Rs=1.87 . The resolution via diastereomeric salt formation of Rac‐HCQ was developed to obtain the active pharmaceutical ingredient of single enantiomer S‐HCQ. Di‐p‐Anisoyl‐L‐Tartaric Acid (L‐DATA) was proved effective as the resolution agent for Rac‐HCQ. Surprisingly, it was found that refluxing time was a key fact affecting the resolution efficiency, which meant the kinetic dominate during the process of the resolution. Four factors—solvent volume, refluxing time, filtration temperature, and molar ratio—were optimized using the single‐factor method and the response surface method. Two cubic models were established, and the reliability was subsequently verified. Under the optimal conditions, the less soluble salt of 2L‐DATA:S‐HCQ was obtained with a yield of 96.9% and optical purity of 63.0%. The optical purity of this less soluble salt increases to 99.0% with a yield of 74.2% after three rounds recrystallization.

Optical Resolution of Two Pharmaceutical Bases with Various Uses of Tartaric Acid Derivatives and Their Sodium Salts: Racemic Ephedrine and Chloramphenicol Base

Optical resolution of 6-fluoro-3, 4-dihydro-2H-1-benzopyran-2-carboxylic acid

Mechanism of Optical Resolutions Via Diastereoisomeric Salt Formation. Part 6 Thermoanalytical investigation of the optical resolution of racemic mandelic acid with S-(+)-2-benzylamino-butanol

Analytical enantioseparation of N-alkyl drugs by reversed-phase liquid chromatography with carboxymethyl--cyclodextrin as mobile phase additive

Optical Resolution of Α-Bromo-2-chlorophenacetic Acid by Way of Coordination with Copper(II) and O,O'-Dibenzoyltartaric Acid

Optical Resolution of DL-Cysteine Hydrochloride with D-(-)-Mandelic Acid

Enantiomeric separation of racemic amlodipine by sequential fractional crystallization through formation of diastereomeric salt solvates and co-crystals of solvate-like compounds with specific structure - A tandem resolution

Novel highly efficient absolute optical resolution method by serial combination of two asymmetric reactions from acetylene monomers having racemic substituents

New methods for resolution of hydroxychloroquine by forming diastereomeric salt and adding chiral mobile phase agent on RP‐HPLC

Synthesis of Hydroxypropyl-β-cyclodextrin Bonded Silica-gel and Its Application to Resolution

Preparation Of D-Tyrosine By Forming Tartaric Acid Dityrosine Ester Diastereomeric Salt

Enantioseparation of 3-phenyllactic acid by chiral ligand exchange countercurrent chromatography.

A Combined Molecular Docking and Chromatographic Study

Comparison of Enantiomeric Resolution of 2,3-Epoxideamides by HPLC on Chiralpak OD and Chiralcel AD Chiral Stationary Phase

Separation Of Terfenadine Enantiomers By High Performance Liquid Chromatography Using Beta-Cyclodextrin As Chiral Mobile Phase Additive

Enantioseparation and Chiral Recognition Mechanism of Two Novel Organic Phosphonate Derivatives on Chiral Stationary Phases

Access to Optically Pure β-Hydroxy Esters via Non-Enzymatic Kinetic Resolution by a Planar-Chiral DMAP Catalyst

OPTICAL RESOLUTION AND DETERMINATION OF PROPAFENONE ENANTIOMERS

Resolving Ketoprofen Using N-Octyl-D-Glucamine As an Optical Resolution Agent

Resolution of Trans‐1,2‐cyclohexanedicarboxylic Acid Containing Two Carboxylic Groups by Forming Diastereomeric Salts Based on Feeding Molar Ratio Control